OCT1 Genetic Variants Influence the Pharmacokinetics of Morphine in Children

• Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA274(23) , 1874–1880 (1995).
   PubMed Web of Science ®Google Scholar
• Anderson BJ , HolfordNH. Tips and traps analyzing pediatric PK data. Paediatr. Anaesth.21(3) , 222–237 (2011).
   PubMed Web of Science ®Google Scholar
• Edwards RR , DoleysDM, FillingimRB, LoweryD. Ethnic differences in pain tolerance: clinical implications in a chronic pain population. Psychosom. Med.63(2) , 316–323 (2001).
   PubMed Web of Science ®Google Scholar
• Edwards RR , MoricM, HusfeldtB, BuvanendranA, IvankovichO. Ethnic similarities and differences in the chronic pain experience: a comparison of African–American, Hispanic, and white patients. Pain Med.6(1) , 88–98 (2005).
   PubMed Web of Science ®Google Scholar
• Rahim-Williams FB , RileyJL, HerreraD, CampbellCM, HastieBA, FillingimRB. Ethnic identity predicts experimental pain sensitivity in African–Americans and Hispanics. Pain129(1–2) , 177–184 (2007).
   PubMed Web of Science ®Google Scholar
• Sadhasivam S , ChidambaranV, NgamprasertwongP et al. Race and unequal burden of perioperative pain and opioid related adverse effects in children. Pediatrics 129(5) , 832–838 (2012).
   PubMed Web of Science ®Google Scholar
• Sadhasivam S , KrekelsEH, ChidambaranV et al. Morphine clearance in children: does race or genetics matter? J. Opioid. Manag. 8(4) , 217–226 (2012).
   PubMedGoogle Scholar
• Coffman BL , RiosGR, KingCD, TephlyTR. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab. Dispos.25(1) , 1–4 (1997).
   PubMed Web of Science ®Google Scholar
• Knibbe CA , KrekelsEH, DanhofM. Advances in paediatric pharmacokinetics. Expert Opin. Drug Metab. Toxicol.7(1) , 1–8 (2011).
   PubMed Web of Science ®Google Scholar
• Tzvetkov MV , StinglJC, BrockmollerJ. Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in the OCT1 gene affect morphine pharmacokinetics. Clin Pharmacol. Ther.91(Suppl. 1) , S105 (2012).
   Web of Science ®Google Scholar
• Jonker JW , SchinkelAH. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1–3). J. Pharmacol. Exp. Ther.308(1) , 2–9 (2004).
   PubMed Web of Science ®Google Scholar
• Koepsell H , EndouH. The SLC22 drug transporter family. Pflugers Arch.447(5) , 666–676 (2004).
   PubMed Web of Science ®Google Scholar
• Nies AT , KoepsellH, WinterS et al. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50(4) , 1227–1240 (2009).
   PubMed Web of Science ®Google Scholar
• Gorboulev V , UlzheimerJC, AkhoundovaA et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 16(7) , 871–881 (1997).
   PubMed Web of Science ®Google Scholar
• Zhang L , DresserMJ, GrayAT, YostSC, TerashitaS, GiacominiKM. Cloning and functional expression of a human liver organic cation transporter. Mol. Pharmacol.51(6) , 913–921 (1997).
   PubMed Web of Science ®Google Scholar
• Saadatmand AR , TadjerpishehS, BrockmollerJ, TzvetkovMV. The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1. Biochem. Pharmacol.83(10) , 1427–1434 (2012).
   PubMed Web of Science ®Google Scholar
• Kerb R , BrinkmannU, ChatskaiaN et al. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. Pharmacogenetics 12(8) , 591–595 (2002).
   PubMedGoogle Scholar
• Shu Y , SheardownSA, BrownC et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J. Clin. Invest. 117(5) , 1422–1431 (2007).
   PubMed Web of Science ®Google Scholar
• Tzvetkov MV , SaadatmandAR, BokelmannK, MeinekeI, KaiserR, BrockmollerJ. Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron. Pharmacogenomics J.12(1) , 22–29 (2012).
   PubMed Web of Science ®Google Scholar
• Tzvetkov MV , SaadatmandAR, LotschJ, TegederI, StinglJC, BrockmollerJ. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol. Clin. Pharmacol. Ther.90(1) , 143–150 (2011).
   PubMed Web of Science ®Google Scholar
• Becker ML , VisserLE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J.9(4) , 242–247 (2009).
   PubMed Web of Science ®Google Scholar
• Tzvetkov MV , VormfeldeSV, BalenD et al. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clin. Pharmacol. Ther. 86(3) , 299–306 (2009).
   PubMed Web of Science ®Google Scholar
• Clavijo CF , HoffmanKL, ThomasJJ et al. A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 400(3) , 715–728 (2011).
   PubMed Web of Science ®Google Scholar
• Savic RM , KarlssonMO. Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions. AAPS J.11(3) , 558–569 (2009).
   PubMed Web of Science ®Google Scholar
• Sadhasivam S , ChidambaranV. Pharmacogenomics of opioids and perioperative pain management. Pharmacogenomics13(15) , 1719–1740 (2012).
   PubMed Web of Science ®Google Scholar
• Po HN , SenozanNM. The Henderson–Hasselbalch equcation: its histroy and limitaions. J. Chem. Educ.78(11) , 1499–1503 (2001).
   Web of Science ®Google Scholar
• Shu Y , BrownC, CastroRA et al. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin. Pharmacol. Ther. 83(2) , 273–280 (2008).
   PubMed Web of Science ®Google Scholar
• Zelcer N , van de Wetering K, Hillebrand M et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc. Natl Acad. Sci. USA102(20) , 7274–7279 (2005).
   PubMed Web of Science ®Google Scholar

▪ Websites

• UGT2B7 allele nomenclature. www.pharmacogenomics.pha.ulaval.ca/files/content/sites/pharmacogenomics/files/Nomenclature/UGT2B/UGT2B7.htm (Accessed 18December2012)
   Google Scholar
• ASA Physical Status Classification System. www.asahq.org/For-Members/Clinical-Information/ASA-Physical-Status-Classification-System.aspx (Accessed 18December2012)
   Google Scholar